GC
ABBV icon

Guilbault Capital’s AbbVie ABBV Stock Holding History

Guilbault Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$598K Sell
2,376
-279
-11% -$60K 0.6% 38
2026
Q1 		$577K Sell
2,655
-48
-2% -$10.6K 0.63% 36
2025
Q4 		$618K Buy
+2,703
New +$616K 0.69% 34

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Guilbault Capital's ABBV Position: Q2 2026 in Review

Guilbault Capital reduced its AbbVie (ABBV) stake by 11% in Q2 2026, selling an estimated $60K and leaving 2,376 shares worth $598K. The position accounts for 0.6% of the portfolio, ranked #38.

Guilbault Capital first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $618K in Q4 2025. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Guilbault Capital held 2,376 shares of AbbVie worth $598K as of Q2 2026.
  • Guilbault Capital sold 279 AbbVie shares in Q2 2026, an estimated $60K.
  • AbbVie made up 0.6% of Guilbault Capital's portfolio in Q2 2026, its #38 holding.
  • Guilbault Capital first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Guilbault Capital's AbbVie position peaked at $618K in Q4 2025.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Guilbault Capital's 13F filing for Q2 2026, filed 23 Jul 2026.